Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam or Haloperidol Premedication for Ketamine Induced Agitation
NCT02909465Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in psychomotor agitation comparing Midazolam, Haloperidol and Placebo (3 arms). Primary endpoints: Agitation and Level of Sedation. Started Jul 2016; status: completed.
02
Drugs
midazolamhaloperidol
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT02909465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909465.